Bader, M. S., Kubetzko, S., Schäfer, B. W., Arranto, C., Drexler, B., Halter, J., . . . Medinger, M. (2024). Minimal residual disease monitoring by Ig/TCR gene rearrangements predicts post-transplant relapse and survival in adult patients with acute lymphoblastic leukemia. Annals of Hematology, 103(11), 4831. https://doi.org/10.1007/s00277-024-05943-1
Chicago Style (17th ed.) CitationBader, Michael Stephan, Susanne Kubetzko, Beat Werner Schäfer, Christian Arranto, Beatrice Drexler, Jörg Halter, Jakob R. Passweg, and Michael Medinger. "Minimal Residual Disease Monitoring by Ig/TCR Gene Rearrangements Predicts Post-transplant Relapse and Survival in Adult Patients with Acute Lymphoblastic Leukemia." Annals of Hematology 103, no. 11 (2024): 4831. https://doi.org/10.1007/s00277-024-05943-1.
MLA (9th ed.) CitationBader, Michael Stephan, et al. "Minimal Residual Disease Monitoring by Ig/TCR Gene Rearrangements Predicts Post-transplant Relapse and Survival in Adult Patients with Acute Lymphoblastic Leukemia." Annals of Hematology, vol. 103, no. 11, 2024, p. 4831, https://doi.org/10.1007/s00277-024-05943-1.
